Publicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (50)

2024

  1. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

    Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473

  2. Review of the allocation criteria for heart transplant in Spain in 2023. SEC-Heart Failure Association/ONT/SECCE consensus document

    Revista Espanola de Cardiologia, Vol. 77, Núm. 1, pp. 69-78

2023

  1. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  2. Impact of physician's perception about LDL cholesterol control in clinical practice when treating patients in Spain

    Atherosclerosis, Vol. 375, pp. 38-44

2022

  1. A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry

    Expert Opinion on Pharmacotherapy, Vol. 23, Núm. 12, pp. 1457-1465

  2. Dyslipidemia observatory: Treatment of hypercholesterolemia in Spain, context and levers for improvement in clinical practice

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 5, pp. 253-260

  3. Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients: A Report From the FANTASIIA Registry

    Frontiers in Cardiovascular Medicine, Vol. 9

  4. Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

    Open Forum Infectious Diseases, Vol. 9, Núm. 9

  5. Prognostic value of a model based on IC-BERG recommendations in ambulatory patients with heart failure

    REC: CardioClinics, Vol. 57, Núm. 2, pp. 76-84

  6. SEA 2022 Standards for Global Control of Cardiovascular Risk

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 3, pp. 130-179

  7. Utility of the IMPACT score for predicting heart transplant mortality. Analysis on a contemporary cohort of the Spanish Heart Transplant Registry

    Clinical Transplantation, Vol. 36, Núm. 9

  8. Valve repair in partial atrioventricular septal defects: the importance of the cleft

    Cirugia Cardiovascular, Vol. 29, Núm. 3, pp. 163-166

2021

  1. A new index to predict quality of anticoagulation control in patients on vitamin K antagonists: The DAFNE score

    Future Cardiology, Vol. 17, Núm. 4, pp. 685-692

  2. Malignancy following heart transplantation: differences in incidence and prognosis between sexes – a multicenter cohort study

    Transplant International, Vol. 34, Núm. 5, pp. 882-893

  3. Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registry

    European Journal of Clinical Investigation, Vol. 51, Núm. 4

  4. Relationship between multimorbidity and outcomes in atrial fibrillation

    Experimental Gerontology, Vol. 153

  5. Spanish Heart Transplant Registry. 32nd Official Report of the Heart Failure Association of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 74, Núm. 11, pp. 962-970

2020

  1. Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry

    Journal of the American Heart Association, Vol. 9, Núm. 1

  2. Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a “Real-world” Nationwide Registry: Insights From the FANTASIIA Study

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 25, Núm. 4, pp. 316-323

  3. Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA study

    Revista Espanola de Cardiologia, Vol. 73, Núm. 1, pp. 14-20